Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.73 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | NT5E | P21589 | 1/20 | 0.68 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | JAK2 | O60674 | 1/20 | 0.62 |
| ▸ | TYK2 | P29597 | 1/20 | 0.62 |
| ▸ | POLB | P06746 | 2/20 | 0.59 |
| ▸ | STAT3 | P40763 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | SCD | O00767 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.55 |
| ▸ | ROCK1 | Q13464 | 3/20 | 0.55 |
| ▸ | NAMPT | P43490 | 2/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7087581 | 0.93 | GAA (0.73) | KDM4EL3MBTL1KMT2ANT5EGAA | |
| SCHEMBL2021051 | 0.88 | MEN1 (0.57) | KDM4EL3MBTL1KMT2AGAAPOLB | |
| SCHEMBL21674204 | 0.88 | MEN1 (0.57) | KDM4EL3MBTL1KMT2AGAAPOLB | |
| SCHEMBL14716526 | 0.86 | KDM4E (1.00) | KDM4EL3MBTL1KMT2ANT5EGAA | |
| SCHEMBL12228179 | 0.83 | KDM4E (0.73) | KDM4EL3MBTL1KMT2ANT5EGAA | |
| SCHEMBL1438598 | 0.83 | KDM4E (0.73) | KDM4EL3MBTL1KMT2ANT5EGAA | |
| SCHEMBL12440844 | 0.83 | MEN1 (0.52) | KDM4EKMT2AGAAPOLBSMN1; SMN2 | |
| SCHEMBL2997631 | 0.83 | PTPN1 (0.65) | KDM4EKMT2APOLBSMN1; SMN2MEN1 | |
| SCHEMBL12993661 | 0.83 | RAB9A (0.70) | KDM4EKMT2APOLBMEN1LMNA | |
| SCHEMBL12440876 | 0.83 | NR1H4 (0.62) | KDM4EKMT2APOLBSTAT3SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8013241-B2 | Ionic gel electrolyte, dye-sensitized photoelectric conversion device and solar cell | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2011-09-06 | — | — | US | disclosed |
| US-7858799-B2 | Ionic organic compound | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2010-12-28 | — | — | US | disclosed |
| US-7858799-B2 | Ionic organic compound | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2010-12-28 | — | — | US | disclosed |
| US-20090266419-A1 | IONIC GEL ELECTROLYTE, DYE-SENSITIZED PHOTOELECTRIC CONVERSION DEVICE AND SOLAR CELL | NATIONAL INSTITUTE OF ADVANCE INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2009-10-29 | — | — | US | disclosed |
| US-20080210907-A1 | Ionic Organic Compound | NAATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2008-09-04 | — | — | US | disclosed |
| US-20080210907-A1 | Ionic Organic Compound | NAATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2008-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080210907-A1 | Ionic Organic Compound | PCNA, INHA, ADM2 | KDM4E 2757/4885L3MBTL1 2059/4885KMT2A 2716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.